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INTRODUCTION 
 
 Subclinical hypocalcemia (SCH) is disorder in which blood Ca concentrations fall 
below a critical threshold as the result of inadequate adaptation to the lactational 
demands for Ca that occur at the onset of colostrum production in dairy cows (Ramberg 
et al., 1970).  Recent research has determined that 11-25% of first lactation animals and 
42-60% of multiparous cows can be categorized as subclinically hypocalcemic in the day 
after parturition (Reinhardt et al., 2011; Caixeta et al., 2015).  This is likely a conservative 
estimate of the true prevalence of SCH after parturition as we continue to learn more 
about the associations between the severity and duration of low blood Ca after parturition 
and negative downstream consequences.  Martinez et al. (2012) demonstrated a strong 
association between SCH and compromised energy metabolism, risk of uterine disease 
and delayed reproduction.  Additional work has found similar associations with 
reproduction (Chapinal et al., 2012) and energy metabolism (Chamberlin et al., 2013) and  
has further demonstrated increased risk for displaced abomasum and early lactation 
culling (Chapinal et al., 2011; Roberts et al., 2012) as well as decreased early lactation 
milk production (Chapinal et al., 2012) in cows with SCH.  Taken together, the body of 
evidence suggests that SCH is a highly prevalent and costly disorder. 
 
 Magnesium is known to be an important mineral in the homeostatic pathway for 
regulating blood Ca from work conducted in cows (van Mosel et al., 1990; van Mosel et 
al., 1991) and humans (Rude et al., 1978; Rude et al., 1985).  Feeding higher 
concentrations of dietary Mg prepartum (0.45-0.50% of DM) has become common 
practice to aid in prevention of hypocalcemia at parturition and has been supported in a 
meta-analysis by Lean et al. (2006).  Postpartum plasma Ca concentrations have been 
shown to take several days to return to prepartum levels (Ramos-Nieves et al., 2009) and 
theoretically, feeding higher concentrations of Mg postpartum may help in the recovery of 
plasma Ca. To the author’s knowledge, feeding varying rates of Mg postpartum to support 
the recovery of blood Ca has not been investigated. 
 
 Mineral status in the transition period may vary based on supplemental mineral 
source due to differences in bioavailability. Bioavailability can be affected by chemical 
structure, particle size or both (Moore et al., 1971; Xin et al., 1989).  Further, mineral 
sources of different chemical structures have been shown to have varying buffering 
capacities (Schaefer et al., 1982), which may aid in intake and performance during the 
transition period where diet transitions have been shown to challenge rumen health 
(Penner et al., 2007).  Investigation of performance of cows in the transition period fed 
varying supplemental mineral sources may provide evidence for strategic use of mineral 
sources to promote successful diet transitions and optimal mineral status.  
 
 The objectives of this experiment were to determine the effects of dietary source 
of supplemental Ca and Mg, and postpartum dietary level of Mg, on intake, performance 
and aspects of energy and mineral metabolism in multiparous Holstein cows.  We 
hypothesized that plasma mineral status would be altered by feeding supplemental 
minerals from a commercial Ca-Mg dolomite and feeding a higher rate of dietary Mg 
postpartum.  If plasma mineral status was improved by either factor, it was hypothesized 
that intake and performance would also be improved in those cows. 
 
EXPERIMENTAL APPROACH 
  
 All animal protocols were approved by the Cornell University Institutional Animal 
Care and Use Committee.  Animals were enrolled in the experiment between May and 
July of 2015. Multiparous Holstein cows (n = 47) were enrolled in a 2 × 2 factorial design 
experiment starting at 28 d prior to expected parturition. Cows were fed a control diet for 
one week and at 21 d prior to expected parturition cows were randomly assigned to 
treatment with randomization restricted to balance for parity group (2nd vs. 3rd and greater 
lactation) and previous lactation 305 d mature equivalent milk production.  Prepartum, 
cows were randomized to one of two source treatments in which supplemental dietary Ca 
and Mg were provided primarily from common sources (Mg oxide and limestone; CS) or 
a commercial Ca-Mg dolomite supplemental mineral source (MIN-AD, Papillon 
Agricultural Company, Easton, MD; MA).  At the next feeding that occurred after calving, 
cows were further randomized to receive diets formulated to contain Mg at close to NRC 
(2001) recommendations or at a higher rate (LM = 0.30% of DM, HM = 0.45% of DM) 
within their source treatments.  Cows were followed through 42 DIM. Criteria for removal 
from the trial included twin calving and calving with less than 10 d on the experimental 
prepartum diet. Cows excluded before the end of the enrollment period were replaced 
and in anticipation of the loss of cows from the trial, one additional cow was enrolled into 
each treatment group at the end of the enrollment period.  The final dataset included 41 
cows from which 11 were in the common source, low Mg group (CS-LM), 11 were in the 
common source, high Mg group (CS-HM), 10 were in the MIN-AD, low Mg group (MA-
LM) and 9 were in the MIN-AD, high Mg group (MA-HM). 
 
Cows were housed in tiestalls and fed once daily at approximately 0800 h for 
lactating cows and 0930 for dry cows.  Individual feed intake was measured on a daily 
basis throughout the experiment by weighing feed delivered and refused.  Cows were fed 
for a targeted refusal rate of 10% to allow for ad libitum intake. Rations were formulated 
using the Cornell Net Carbohydrate and Protein System (CNCPS v. 6.5). Ingredient 
composition and analyzed diet composition of all prepartum and postpartum treatment 
diets are presented in Tables 1 and 2.  All rations were composed of a base TMR 
containing forages and a base grain mix as well as a small inclusion rate grain mix 
(containing supplemental minerals).  The base TMR was mixed in one batch for all 
prepartum cows and in one batch for all postpartum cows.  Prior to delivery to the cow, 
smaller batches were made which included the small inclusion rate grain mixes. Samples 
of TMR and all feed ingredients were collected weekly for determination of DM (dried at 
40°C for 96 h).  Weekly dry matters were used to adjust as fed inclusion rates of all 
forages and grain ingredients and to calculate DMI.  At the end of the experiment, dried 
samples were ground to 2 mm in a Wiley mill and composited at 4 wk intervals for TMR 
samples and over the duration of the trial for all forages and grains. Composited samples 
were sent to a commercial laboratory (Cumberland Valley Analytical Services, 
Hagerstown, MD) for wet chemistry analysis. 
 
Cows were observed daily throughout the experiment for health disorders. Body 
weights were measured weekly and BCS assigned by two scorers weekly according to 
Edmonson et al. (1989) beginning during the week prior to assignment to treatment and 
continuing through 42 d postpartum.  Body condition scores were averaged over two 
scorers before statistical analysis. 
 
After calving, all cows were milked three times daily at 0600 h, 1400 h and 2200 h 
and milk weights recorded. Milk samples were collected at 3 consecutive milkings each 
week and analyzed at a commercial laboratory (DairyOne, Ithaca, NY) for milk fat, protein, 
lactose, total solids and MUN using mid-infrared techniques (Method 972.16, (AOAC 
International, 2006)  and SCC was determined by optical fluorescence (Method 978.26, 
(AOAC International, 2006).  Somatic cell scores were calculated from SCC (SCS = 
log2(SCC/100,000)+3).  Milk yield at the corresponding milking was used to weight milk 
composition and calculate yield of fat, protein, lactose and total solids.  Weekly average 
yield of 3.5% FCM was calculated [3.5% FCM = (0.432 × kg of wk average milk yield) + 
(16.216 × kg of fat)] as well as weekly average yield of ECM [ECM = (0.327 × kg of wk 
average milk yield) + (12.95 × kg of fat) + (7.65 × kg of true protein)].  Milk production 
efficiency was calculated from weekly average DMI and ECM (efficiency = kg of ECM/ kg 
of DMI). Weekly energy balance (EBAL) was calculated according to NRC (2001). 
 
Blood samples were collected via coccygeal venipuncture between 0600 h and 
0730 h 2×/wk from d -28 relative to expected parturition until parturition (Monday and 
Friday), within 2 h of parturition (d 0), daily from d 1 through 7 in milk, and 3×/wk thereafter 
(Monday, Wednesday and Friday) through 21 DIM.  Plasma was harvested and snap 
frozen in liquid nitrogen and stored at -20°C until analysis.   A subset of samples were 
analyzed using commercial enzymatic kits for β-hydroxybutyrate (BHBA; Catachem Inc., 
Oxford, CT) and non-esterified fatty acids (NEFA; HR Series NEFA HR (2), Wako Pure 
Chemical Industries, Osaka, Japan). Mineral concentrations were determined at the 
Cornell Animal Health and Diagnostic Center (Ithaca, NY) on an automated analyzer 
(Hitachi Modular P800, Roche Diagnostics, Indianapolis, IN). 
 
STATISTICAL ANALYSIS 
 
Prepartum and postpartum data were analyzed separately.  All statistical analyses 
were conducted with the statistical software SAS (version 9.4, SAS Institute Inc., Cary, 
NC). All measurements repeated over time were subjected to repeated measures 
analysis using the REPEATED statement in the MIXED procedure of SAS (Littell et al., 
1996).  The fixed effects of time, source, level (postpartum only), parity group (2nd vs. 3rd+ 
lactation) and the two- and three-way interactions of source, level (postpartum only) and 
time were included in the model.   
 
Table 1. Ingredient composition of prepartum and postpartum diets 
 Prepartum Diet1  Postpartum Diet1 
Ingredient (% of DM) CS MA  CS-LM CS-HM MA-LM MA-HM 
Brown mid-rib corn silage 37.59 37.59  38.00 38.00 38.00 38.00 
Alfalfa hay - -  7.60 7.60 7.60 7.60 
Wheat straw 23.23 23.23  6.21 6.21 6.21 6.21 
Corn grain, finely ground  2.29 2.29  17.10 17.10 17.10 17.10 
Wheat midds 6.54 6.54  4.71 4.71 4.71 4.71 
Citrus pulp 4.31 4.31  4.75 4.75 4.75 4.75 
Soybean hulls 6.50 6.50  2.13 2.13 2.13 2.13 
Canola meal 3.33 3.33  3.80 3.80 3.80 3.80 
Corn gluten feed 1.67 1.67  2.37 2.37 2.37 2.37 
Distillers 1.09 0.62  1.29 1.02 1.13 0.58 
Amino Plus2 2.32 2.32  5.70 5.70 5.70 5.70 
Gemini Protein3 1.99 1.99  2.28 2.28 2.28 2.28 
Energy Booster 1004 - -  1.14 1.14 1.14 1.14 
Biochlor5 5.56 5.56  - - - - 
Alimet6 0.07 0.07  0.06 0.06 0.06 0.06 
Salt 0.33 0.33  0.57 0.57 0.57 0.57 
Sodium bicarbonate - -  0.38 0.38 0.38 0.38 
Limestone 2.46 1.49  1.35 1.38 1.08 0.47 
Ca sulfate - -  0.25 0.25 0.25 0.25 
Mg oxide 0.41 0.09  0.13 0.38 0.05 0.08 
MIN-AD7 - 1.78  - - 0.52 1.66 
Mineral oil 0.02 0.02  0.02 0.02 0.02 0.02 
Rumensin8  0.04 0.04  0.06 0.06 0.06 0.06 
Trace minerals & vitamins 0.21 0.21  0.04 0.04 0.04 0.04 
1Treatments consist of a 2 × 2 factorial arrangement of source assignments (CS = common 
sources of supplemental minerals, MA = supplemental minerals from a commercial source) 
beginning at 21 d prior to due date, and level assignments (LM = formulated diet Mg at 0.30% of 
DM, HM = formulated diet Mg at 0.45% of DM) beginning within 1 d after parturition.  
Treatments were continued through 42 DIM. 
2Ag Processing, Inc. Omaha, NE 
3Papillon Agricultural Company, Inc., Easton, MD 
4Milk Specialties Global, Eden Prairie, MN 
5Church & Dwight Co., Inc., Trenton, NJ 
6Novus International, Saint Charles, MO 
7Papillon Agricultural Company, Easton, MD 
8Elanco Animal Health, Greenfield, IN. Contained 26,400 g/ton monensin. 
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Cow within source (prepartum) or source and level (postpartum) was the random effect. 
When available, covariate measurements collected in the week prior to treatment 
assignment were included in all models.  Previous lactation 305 d mature equivalent milk 
production was included as a covariate for milk yield. The Kenward Rogers method was 
used for estimation of denominator degrees of freedom.  Four covariance structures were 
tested for each model and the model with the lowest Aikaike’s Information Criterion was 
selected. When P ≤ 0.10 for interactions with time, the SLICE option was used in the 
LSMEANS statement to conduct an F-test to determine at which levels of time the 
treatment groups differed. When non-normality of residual variance was evident (NEFA 
and postpartum BHBA), data were log transformed and analysis repeated.  Least squares 
means and standard errors, or geometric mean and confidence intervals (NEFA and 
postpartum BHBA), are reported throughout.  Significance was declared at P ≤ 0.05 and 
trends are discussed at 0.05 < P ≤ 0.10.  
 
RESULTS 
 
 Analyzed dietary Mg concentration of postpartum treatment diets were different 
from formulated (Table 2).  Both of the LM diets had analyzed Mg concentrations of 0.35% 
of DM, above the targeted 0.30% of DM.  The concentration of Mg in the HM diets was 
higher than the LM diets, however, they were different from one another with the CS-HM 
diet at 0.40% of DM and the MA-HM diet at 0.48% of DM. Intake of Mg and Ca from 
supplemental sources versus basal ingredients is also presented in Table 2. Overall, 
differences in level of Mg were apparent, justifying analysis of data for any effects of level.  
As will be discussed, level effects were minimal and this may have been due at least in 
part to the variation in actual diet Mg concentrations versus the formulated composition. 
The population of cows in this trial was exceptionally healthy presenting a challenging 
test of the source and level treatments.  Incidence of retained placenta and displaced 
abomasum were both 2% (n = 1/41), incidence of metritis was 17% (n = 7/41) and only 2 
cows had at least one case of clinical mastitis during the study period (5%). 
 
 Prepartum DMI was affected by supplemental mineral source and cows fed 
supplemental minerals primarily from MIN-AD had higher DMI (CS = 17.0 vs. MA = 17.8 
kg/d, P = 0.05, Figure 1).  Similarly, DMI as a percent of BW was higher in cows fed MA 
(CS = 2.13 vs. MA = 2.23% of BW, P = 0.05). An interaction of source, level and time was 
observed for postpartum DMI (P = 0.01; Figure 1) and DMI as a percent of BW (P = 0.05) 
and DMI appeared to be higher for cows fed MA-HM in wk 2 postpartum and for cows fed 
CS-HM in wk 4, however, none of the slice effects at particular weeks were significant. 
Previous work suggests that chemical composition and quality of processing of Mg 
sources can impact buffering capacity (Schaefer et al., 1982). While the buffering capacity 
of the mineral sources was not tested in this trial, it is possible that a higher buffering 
capacity of MIN-AD contributed to differences in DMI. While this is plausible postpartum 
as cows transition onto higher starch postpartum diets, it is unlikely during the prepartum 
period when cows are consuming low starch, high fiber diets. A previous trial 
demonstrated that cows fed dolomitic minerals had decreased fiber digestions and 
increased passage rate (Moore et al., 1971), which may be another potential mechanism 
for higher intake in cows fed MA.  
Week Relative to Calving     
Figure 1. Least squares means and standard errors for DMI in the 3 wk prepartum period 
 and from wk 1 through 6 postpartum 
 
Calculated EBAL was similarly affected prepartum by supplemental mineral source 
and EBAL tended to be higher for cows fed MA (CS = 8.8 vs. MA = 10.0 Mcal/d, P = 0.06).  
There were no significant effects on EBAL postpartum.  Prepartum and postpartum 
plasma concentrations of NEFA and BHBA are presented in Figure 2. As expected based 
on the effects on DMI, plasma concentrations of NEFA prepartum were lower in cows fed 
MA (P = 0.004).  Cows fed MA also tended to have lower NEFA in the postpartum period 
(P = 0.09).  There were no effects of treatment on prepartum plasma concentrations of 
BHBA but there was a trend for an interaction of source and level on postpartum plasma 
BHBA concentrations (P =0.09) and BHBA concentrations were numerically lowest in 
cows fed MA-LM but multiple comparisons using Tukey’s adjustment did not reveal 
differences between specific groups. 
 
Results for milk yield, milk composition and milk production efficiency are 
presented in Table 3.  There were no effects of source or level on milk yield, protein 
content, protein yield, lactose content, lactose yield, total solids content, milk production 
efficiency or somatic cell score.  An interesting source by week effect was found for fat 
content (P = 0.07), fat yield (P =0.02), fat-corrected yield (P =0.04), total solids yield (P 
=0.05) and energy-corrected yield (P =0.03).  These effects are driven by higher content 
and yield of fat in wk 1 for cows fed MA (P < 0.05).  Considering the trend for lower plasma 
NEFA concentrations in the first 21 d postpartum for cows fed MA, it is hypothesized that 
the additional source of milk fat is not from the mobilization of body reserves as is typically 
expected when fat content is higher immediately after parturition. The DIM at which the 
first week’s milk sampling occurred tended to be lower for cows fed CS compared to cows 
fed MA (CS = 3.3 vs. MA = 4.3 DIM; P = 0.09), suggesting that higher fat content due to 
colostrum composition is not responsible for this source effect. Controlling for the random 
effect of DIM within sampling week did not alter interpretation of the data and therefore 
was not included in the final analysis. 
 
 
14
16
18
20
22
24
26
‐3 ‐2 ‐1
DM
I(
kg
/d
)
CS
MA
1 2 3 4 5 6
CS‐LM
CS‐HM
MA‐LM
MA‐HM
Day Relative to Calving 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Geometric means and back transformed 95% confidence limits, or least  
 squares means and 95% confidence intervals (prepartum BHBA), for NEFA 
and BHBA for the 3 wk prepartum and postpartum 
 
Postpartum plasma mineral concentrations over time are presented in Figure 4. 
There were no overall effects of dietary supplemental mineral source on prepartum 
plasma concentrations of Ca (CS = 2.44 vs. MA = 2.44 mmol/L; P = 0.85) or Mg (CS = 
0.96 vs. MA = 0.96 mmol/L; P = 0.59), although cows fed MA had higher concentrations 
of P in plasma prepartum (CS = 1.69 vs. MA = 1.79 mmol/L; P = 0.02).    Postpartum 
plasma P tended to be higher for cows fed MA (P = 0.09), consistent with the effects in 
the prepartum period.  Higher plasma P concentrations have been demonstrated when 
intake of P is increased (Barton et al., 1987) and higher intake for cows fed MA may be 
responsible for higher plasma P concentrations. Postpartum plasma Mg tended to be 
lower for cows fed LM compared to cows fed HM (P = 0.11) which would be expected in 
diets with lower Mg supply (van Mosel et al., 1991).  Postpartum plasma Mg also tended 
to be lower for cows fed MA compared to cows fed CS (P = 0.10).  Some work has 
demonstrated competitive inhibition of Mg absorption as dietary concentration, or ruminal 
concentration, of Ca increased (Care et al., 1984; Kronqvist et al., 2011).  If ruminal 
concentration of Ca was higher in cows fed MA due to higher intake of Ca, or greater 
solubility of that Ca, this could have contributed to lower plasma Mg postpartum in cows 
fed MA. There is evidence from work in steers suggesting that apparent Mg absorption 
from Ca-Mg dolomites is lower than that of Mg oxide (Moore et al., 1971) and lower 
absorption coefficients are assigned to Ca-Mg dolomites by the NRC (2001). However, 
minimal work has been done assessing bioavailability of Mg sources in lactating dairy 
cows, especially that comparing different sources, particle sizes and rumen conditions. 
There were no effects of source or level on postpartum plasma Ca concentrations despite 
alterations in plasma Mg. Incidence of hypocalcemia (plasma Ca < 2.125 mmol/L) was 
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low in this trial.  Peak prevalence of hypocalcemia was 51% at 1 DIM and was reduced 
to 27% at 2 DIM, 7% at 3 DIM and by 4 DIM no cows had plasma Ca < 2.125 mmol/L. 
 
Table 3.  Least squares means and standard error for milk yield, milk composition, and 
milk production efficiency over the first 6 wk postpartum 
 Treatments1  P-values2 
Variable 
CS-
LM 
CS-
HM 
MA-
LM 
MA-
HM SEM S L S×T L×T S×L 
S×L×
T 
Milk yield (kg/d) 45.0 46.5 45.9 44.0 1.8 0.64 0.89 0.19 0.47 0.30 0.54 
Fat (%) 3.85 3.72 3.84 3.94 0.11 0.35 0.90 0.07 0.01 0.34 0.84 
Fat (kg/d) 1.68 1.68 1.75 1.72 0.09 0.51 0.81 0.02 0.44 0.88 0.82 
3.5% FCM (kg/d) 46.9 47.5 48.4 46.7 2.0 0.85 0.77 0.04 0.27 0.54 0.73 
Protein (%) 2.86 2.81 2.83 2.87 0.07 0.78 0.90 0.64 0.50 0.49 0.55 
Protein (kg/d) 1.24 1.24 1.29 1.23 0.05 0.67 0.49 0.18 0.41 0.55 0.24 
Lactose (%) 4.86 4.84 4.81 4.87 0.05 0.85 0.72 0.29 0.97 0.50 0.97 
Lactose (kg/d) 2.18 2.23 2.24 2.14 0.10 0.86 0.76 0.26 0.90 0.44 0.66 
Total solids (%) 12.5 12.3 12.4 12.6 0.2 0.51 0.94 0.38 0.32 0.36 0.77 
Total solids (kg/d) 5.53 5.56 5.72 5.50 0.25 0.78 0.69 0.05 0.68 0.61 0.51 
ECM (kg/d) 46.1 46.5 47.6 45.9 1.9 0.80 0.70 0.03 0.50 0.54 0.58 
ECM/DMI 2.12 2.09 2.17 2.03 0.07 0.91 0.21 0.28 0.84 0.43 0.46 
MUN (mg/dL) 6.74 6.58 7.30 6.61 0.35 0.37 0.20 0.74 0.06 0.43 0.47 
1Treatments consist of a 2 × 2 factorial arrangement of source assignments (C = common sources 
of supplemental minerals, M = supplemental minerals from a commercial source) beginning at 21 
d prior to due date and level assignments (LM = formulated diet Mg at 0.30% of DM, HM = 
formulated diet Mg at 0.45% of DM) beginning within 1 d after parturition. Treatments were 
continued through 42 DIM. 
2S = source; L = level; T = time 
 
 
 
Figure 4.  Least squares means and standard errors for plasma Ca, Mg and P from d 1  
through 7 postpartum  
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CONCLUSIONS AND IMPLICATIONS 
 
 This experiment found that cows fed supplemental minerals from a commercial 
Ca-Mg dolomite source, compared to commonly used Mg oxide and limestone, had 
higher intakes in the prepartum period leading to lower concentrations of NEFA in plasma 
prepartum.  Lower NEFA concentrations for cows fed MA tended to carry over into the 
postpartum period. The data also indicate potential intake advantages for cows fed MA in 
portions of the postpartum period.  Results from this experiment suggest that there is 
opportunity for strategic use of mineral sources to aid in DMI and energy metabolism 
during the transition period.  
Effects of dietary Mg level were minimal despite a tendency for cows fed LM to 
have lower plasma Mg concentrations. Neither dietary mineral source, nor level of Mg, 
influenced plasma Ca concentrations in the peripartum period. This suggests that in this 
study, feeding 0.35% of DM as Mg using either source was sufficient to support plasma 
Ca, resulting in low prevalence of hypocalcemia and a rapid recovery of blood Ca. This 
population of cows was exceptionally healthy and similar work in a study population with 
more severe mineral homeostasis challenges at parturition is warranted. 
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